Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03717935 · ClinicalTrials.gov registry record · NA

Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS

A NA study of Obesity and Hepatic Steatosis, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT03717935 is a NA study of Obesity and Hepatic Steatosis that has completed, run by University of Colorado, Denver. The registered enrollment target is 27 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03717935, a NA study of Obesity and Hepatic Steatosis, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The Investigators will measure hepatic glucose and fat metabolism in obese girls with Polycystic Ovarian Syndrome (PCOS) and hepatic steatosis (HS) after taking 4 weeks of an essential amino acid (EAA) supplement or placebo and test whether the EAA supplement can improve hepatic glucose metabolism in these girls.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Essential Amino Acid (EAA) Supplement

Study Locations (1)

Colorado

  • University of Colorado, Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2018-10-08
Est. Completion 2022-01-14
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT03717935

The ClinicalTrials.gov registry entry for NCT03717935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03717935 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03717935 about?

NCT03717935 is a clinical study titled "Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS". The Investigators will measure hepatic glucose and fat metabolism in obese girls with Polycystic Ovarian Syndrome (PCOS) and hepatic steatosis (HS) after taking 4 weeks of an essential amino acid (EAA) supplement or placebo and test whether the EAA supplement can improve hepatic glucose metabolism i...

What is the current status of trial NCT03717935?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-10-08. Estimated completion is 2022-01-14.

What conditions does trial NCT03717935 study?

This clinical trial studies the following conditions: Obesity, Hepatic Steatosis, Polycystic Ovarian Syndrome.

What interventions are being tested in trial NCT03717935?

The interventions under investigation include: Placebo (OTHER), Essential Amino Acid (EAA) Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03717935?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03717935 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.